- $121.93bn
- $140.83bn
- £32.67bn
- 98
- 63
- 99
- 99
REG - GSK PLC - US FDA Fast Track designation for bepirovirsen
AnnouncementREG - GSK PLC - Shingrix 18+ at risk China filing review accepted
AnnouncementREG - GSK PLC - FDA accepts Arexvy filing for adults 50-59 at risk
AnnouncementREG - GSK PLC - GSK presents positive DREAMM-7 phase III data
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Final Results
AnnouncementREG - GSK PLC - EMA accepts Arexvy filing for adults 50-59 at risk
AnnouncementREG - GSK PLC - European Commission authorises Omjjara in the EU
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK completes sale of shares in Haleon plc
AnnouncementREG - GSK PLC - GSK announces intention to sell shares in Haleon
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Nucala approved in China for use in severe asthma
AnnouncementREG - GSK PLC - GSK enters agreement to acquire Aiolos Bio
Announcement